PA8505301A1 - Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina - Google Patents

Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina

Info

Publication number
PA8505301A1
PA8505301A1 PA20008505301A PA8505301A PA8505301A1 PA 8505301 A1 PA8505301 A1 PA 8505301A1 PA 20008505301 A PA20008505301 A PA 20008505301A PA 8505301 A PA8505301 A PA 8505301A PA 8505301 A1 PA8505301 A1 PA 8505301A1
Authority
PA
Panama
Prior art keywords
evil
tetrahydrotetraline
propilamine
ceto
administration
Prior art date
Application number
PA20008505301A
Other languages
English (en)
Inventor
Durk Dijkstra
Leonard Theodore Meltzer
Bastiaan Johan Venhuis
Original Assignee
Warner Lambertcompany
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambertcompany filed Critical Warner Lambertcompany
Publication of PA8505301A1 publication Critical patent/PA8505301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL MAL DE PARKINSON SE TRATA CON UN COMPUESTO DE LA FORMULA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
PA20008505301A 1999-10-20 2000-10-18 Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina PA8505301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16071699P 1999-10-20 1999-10-20

Publications (1)

Publication Number Publication Date
PA8505301A1 true PA8505301A1 (es) 2002-12-30

Family

ID=22578122

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008505301A PA8505301A1 (es) 1999-10-20 2000-10-18 Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina

Country Status (8)

Country Link
AR (1) AR026086A1 (es)
AU (1) AU1209501A (es)
CO (1) CO5251402A1 (es)
GT (1) GT200000182A (es)
PA (1) PA8505301A1 (es)
PE (1) PE20010746A1 (es)
SV (1) SV2001000202A (es)
WO (1) WO2001028977A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463119A4 (en) * 1989-07-05 1992-01-22 Whitby Research Incorporated Substituted 2-aminotetralins
WO2000006536A1 (en) * 1998-07-28 2000-02-10 Warner-Lambert Company Hexahydro-naphthalenone oximes and hydrazones

Also Published As

Publication number Publication date
SV2001000202A (es) 2001-10-16
WO2001028977A1 (en) 2001-04-26
PE20010746A1 (es) 2001-07-27
AU1209501A (en) 2001-04-30
CO5251402A1 (es) 2003-02-28
AR026086A1 (es) 2002-12-26
GT200000182A (es) 2002-04-12

Similar Documents

Publication Publication Date Title
LU92204I2 (fr) Dapoxetine sous toutes ses formes protégées par lebrevet de base
AP2002002637A0 (en) Novel piperazine
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
AR024077A1 (es) Compuestos antibacterianos
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
RU2011138835A (ru) Применение производного рапамицина
CO5690131A1 (es) Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento de transtornos del snc
EA200801806A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
MY119375A (en) Treatment of tinnitus using neuroprotective agents
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
AR032432A1 (es) Combinaciones oncoliticas para el tratamiento de cancer
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DE60128100D1 (de) Analgetisches arzneimittel
SE9900070D0 (sv) New use
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
PA8505301A1 (es) Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina
AP2002002595A0 (en) Heterocyclic amide derivatives.
UY26405A1 (es) Método para tratar el mal de parkinson a través de la administración de (-)-5-ceto-2-n,n-d1-n-propilamino-tetrahidrotetralina.
ECSP003725A (es) Metodo para tratar el mal de parkinson a travez de la administracion de (-) -5- ceto-2-n, n-d1-n-propilamino-tetrahidrotetralina
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
PT1183046E (pt) Derivado de aminotetralina para a terapia de doencas cardiovasculares
NO20003785D0 (no) Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon